企業プロフィール

Elevance Health 株価・ニュース・カタリスト

ティッカー:
ELV
取引所:
NYSE
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

390.24 USD (-2.52%)

終値

最終更新: 2026年8月17日

84.5B USD

時価総額

株価変動の要因

As of Aug 17, 2026, ELV closed down 2.52% at $390.24. No new same-company headline was identified in the current news window.

企業概要

事業概要

Elevance Health is a diversified healthcare company focused on health benefits, care delivery, and services. Its story is shaped by managed-care scale, medical cost discipline, and the breadth of its healthcare platform.

所在地とセクター分類

Headquartered in the United States and listed on NYSE, Elevance is primarily a U.S.-focused managed-care company. Its footprint is broad across commercial, government, and specialty healthcare programs.

ビジネスモデルの特徴

The business depends on premium revenue, healthcare services, and effective management of medical cost trends. Investors watch membership, pricing, care utilization, and operating discipline rather than drug-development catalysts.

バイオ業界での位置付け

Elevance is not a biotech name, but it matters to healthcare investors because it sits at the payer-services core of the system. Its stock is driven by utilization and policy sensitivity, not clinical trial events.

今後のカタリスト

  • Elevance Health’s catalysts are earnings, medical-benefit ratio commentary, and any update on Medicaid or Medicare utilization trends. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.

最近のニュース

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。